Cargando…

Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study

BACKGROUND: Treatment with vitamin K antagonists (VKA) requires a high proportion of time in the therapeutic range (TTR) and a low international normalised ratio (INR) variability to be maximally safe and effective. Switching from short-acting acenocoumarol to long-acting phenprocoumon could improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Miert, Jasper H. A., Veeger, Nic J. G. M., ten Cate-Hoek, Arina J., Piersma-Wichers, Margriet, Meijer, Karina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351201/ https://www.ncbi.nlm.nih.gov/pubmed/32649714 http://dx.doi.org/10.1371/journal.pone.0235639

Ejemplares similares

Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis
por: van Miert, Jasper H. A., et al.
Publicado: (2018)

Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
por: Geisen, Christof, et al.
Publicado: (2010)

Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)

Acenocoumarol’s pharmacokinetic: linear or not?
por: Kumar, Parveen, et al.
Publicado: (2019)

Acenocoumarol: Lack of efficacy: case report
Publicado: (2022)

Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis
por: Russ, Philipp, et al.
Publicado: (2019)

Prevention and treatment of the post‐thrombotic syndrome
por: ten Cate‐Hoek, Arina J.
Publicado: (2018)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

The Role of Clinical Variables and VKORC1 Polymorphism in Efficacy and Stability of Acenocoumarol in Neurological Patients
por: Kumar, Surendra, et al.
Publicado: (2018)

Toxidermie médicamenteuse secondaire à l'acénocoumarol
por: Khammassi, Naziha, et al.
Publicado: (2015)

Massive intoxication with rivaroxaban, phenprocoumon, and diclofenac: A case report
por: Pfeiffer, Hella, et al.
Publicado: (2016)

Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review
por: Notten, Pascale, et al.
Publicado: (2021)

Postoperative thromboembolic prophylaxis in joint replacement surgery: Guidelines and daily practice
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2012)

The effect of stopping phenprocoumon 5 days preoperatively: A retrospective study
por: Knol, Silke, et al.
Publicado: (2018)

Thrombosis of A Prosthetic Mitral Valve After Withdrawal of Phenprocoumon Therapy
por: Wilke, Andreas, et al.
Publicado: (2011)

The influence of excessive consumption of liquorice on phenprocoumon (Marcumar®): a case report
por: Roemer, Hermann Casper, et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Atomkärnans inre omprövas
por: Kullander, Sven
Publicado: (1986)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms
por: Schneider, Katharina Luise, et al.
Publicado: (2020)

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction
por: Nagler, Michael, et al.
Publicado: (2018)

Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements
por: Anton, Ana Isabel, et al.
Publicado: (2013)

Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis
por: Warzecha, Zygmunt, et al.
Publicado: (2016)

Unusual localization of bleeding under acenocoumarol: Spinal subdural hematoma
por: Aissa, Ismail, et al.
Publicado: (2019)

Acenocoumarol-Induced Diffuse Alveolar Hemorrhage: A Case Report
por: Pawar, Twinkle, et al.
Publicado: (2023)

Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review
por: Zwaveling, Suzanne, et al.
Publicado: (2018)

Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing
por: Bloemen, Saartje, et al.
Publicado: (2017)

P1647: CHRONIC INFLAMMATORY DISEASES INCREASE THE RISK OF POST-THROMBOTIC SYNDROME: A PROSPECTIVE COHORT STUDY
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis
por: Kremers, Bram, et al.
Publicado: (2020)

Using the Functional Resonance Analysis Method to explore how elastic compression therapy is organised and could be improved from a multistakeholder perspective
por: Schreurs, Rachel Hellen Petra, et al.
Publicado: (2021)

Development of a Consensus-Based Cross-Domain Protocol for the Management of Elastic Compression Stocking Therapy in Patients With Deep Venous Thrombosis and Chronic Venous Disease: A Modified Delphi Study
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
por: Schreurs, Rachel H. P., et al.
Publicado: (2023)

Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes
por: Remer, Hallie B., et al.
Publicado: (2022)

Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service
por: Hawkins, Kelsey L., et al.
Publicado: (2018)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
por: Sawicka-Powierza, Jolanta, et al.
Publicado: (2018)

Unintentional ingestion of a high dose of acenocoumarol in a young child
por: Brands, Martijn R, et al.
Publicado: (2021)

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2014)

Screen or not to screen for peripheral arterial disease: guidance from a decision model
por: Vaidya, Anil, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4p9gtms2q5ru73l9dfp3fhu5u1